Pharmacokinetics and Relative Bioavailability Study

Summary

Pharmacokinetics and Relative Bioavailability Study is a clinical trial^[1].

Key Facts

• Pharmacokinetics and Relative Bioavailability Study is in the country of Singapore^[2].
• Pharmacokinetics and Relative Bioavailability Study's instance of is recorded as clinical trial^[3].
• Pharmacokinetics and Relative Bioavailability Study's start time is recorded as +2011-10-31T00:00:00Z^[4].
• Pharmacokinetics and Relative Bioavailability Study's end time is recorded as +2011-11-30T00:00:00Z^[5].
• Pharmacokinetics and Relative Bioavailability Study's sponsor is recorded as Pfizer^[6].
• Pharmacokinetics and Relative Bioavailability Study's main subject is recorded as pharmacokinetics^[7].
• Pharmacokinetics and Relative Bioavailability Study's number of participants is recorded as {'unit': '1', 'amount': '+16'}^[8].
• Pharmacokinetics and Relative Bioavailability Study's title is recorded as A Single-Dose Pharmacokinetics And Relative Bioavailability Study Of Tolterodine From Two Microspheres In Powder Blend Extended Release Formulations Compared To The Commercial Extended Release Capsules^[9].
• Pharmacokinetics and Relative Bioavailability Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+21'}^[10].
• Pharmacokinetics and Relative Bioavailability Study's ClinicalTrials.gov ID is recorded as NCT01521767^[11].
• Pharmacokinetics and Relative Bioavailability Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+55'}^[12].
• Pharmacokinetics and Relative Bioavailability Study's research intervention is recorded as tolterodine tartrate^[13].
• Pharmacokinetics and Relative Bioavailability Study's clinical trial phase is recorded as phase I clinical trial^[14].
• Pharmacokinetics and Relative Bioavailability Study's research site is recorded as Pfizer^[15].
• Pharmacokinetics and Relative Bioavailability Study's study type is recorded as interventional study^[16].